Open access
588
Views
92
CrossRef citations to date
0
Altmetric
Original Research
LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis
Gustavo J Rodrigo1 Departamento de Emergencia, Hospital Central de las Fuerzas Armadas, Montevideo, UruguayCorrespondence[email protected]
, David Price2 Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, Scotland, UK;3 Observational and Pragmatic Research Institute, Singapore
, Antonio Anzueto4 University of Texas Health Science Center;5 South Texas Veterans Health Care System, San Antonio, TX, USA
, Dave Singh6 Medicines Evaluation Unit, National Institute for Health Research Respiratory and Allergy Clinical Research Facility, University Hospital of South Manchester NHS Foundation Trust, University of Manchester, Manchester, England, UK
, Pablo Altman7 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
, Giovanni Bader8 Novartis Pharma AG, Basel, Switzerland
, Francesco Patalano8 Novartis Pharma AG, Basel, Switzerland
, Robert Fogel7 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
& Konstantinos Kostikas8 Novartis Pharma AG, Basel, Switzerland
show all
Pages 907-922
|
Published online: 17 Mar 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.